Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) has seen a rise in its stock price target to $16 from $14 by Bank of America Securities, after raising $175 million.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
BofA Securities Lifts Amylyx Pharmaceuticals Inc. (AMLX) Price Target Amid Bolstered Balance Sheet
